Position in AVNS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,372,419
+$228,251 QoQ
Shares Held
97,960
-3.9% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AVNS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MOORE CAPITAL MANAGEMENT, LP holds $17,120,804 across 7 Medical Devices names. AVNS ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
25,000 | $8,209,250 | |
| 2 | BRKR |
Bruker Corp
|
75,482 | $2,726,409 | |
| 3 | MASI |
Masimo Corp
|
10,020 | $1,782,257 | |
| 4 | INGN |
Inogen Inc
|
279,899 | $1,729,775 | |
| 5 | AVNS |
Avanos Medical, Inc.
This page
|
97,960 | $1,372,419 | |
| 6 | CNMD |
CONMED Corp
|
24,579 | $869,113 | |
| 7 | RXST |
RxSight, Inc.
|
70,062 | $431,581 |
All Filings in AVNS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,372,419 | 97,960 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,144,168 | 101,885 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,020,274 | 88,259 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $654,191 | 53,447 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $878,242 | 61,287 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $590,154 | 37,070 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||